CiplaQCIL is committed to making the highest quality, affordable, life-saving medicines because we want people to live a long and healthy life. We see a future where good health is expected – not for the few but for the many. That’s why we believe no-one should be denied access to essential medicine. We’re not just about making medicine, we’re about making a difference.

CiplaQCIL continually strives to produce quality, affordable medicines that will meet the demands of the increasing African population. In addition to producing medicine to treat malaria, HIV and Hepatitis B, CiplaQCIL is exploring the production of medicine to manage the surge of non-communicable diseases (NCDs) and cancer. In September 2018, following a successful Initial Public Offering, CiplaQCIL shares were listed on the Uganda Securities Exchange for the first time.

CiplaQCIL employs more than 350 permanent staff of which 38% is female. We are an equal opportunity employer and does not discriminate on gender, age, disability, ethnicity, religious grounds, or nationality. We take immense pride in developing and training staff to empower them and enhance their ability to deliver the best results for the business.